Literature DB >> 9790432

Hepatitis C virus genotypes and hepatitis G virus in hemodialysis patients from Syria: identification of two novel hepatitis C virus subtypes.

A S Abdulkarim1, N N Zein, J J Germer, C P Kolbert, L Kabbani, K L Krajnik, A Hola, M N Agha, M Tourogman, D H Persing.   

Abstract

High prevalence of hepatitis C (HCV) and hepatitis G (HGV) viruses has been reported among hemodialysis patients with substantial heterogeneity of HCV genotypes throughout the world. We studied HCV prevalence, clinical significance, genotype distribution, and HGV coinfection in hemodialysis patients from Syria. Ninety (75%) of 120 screened patients were HCV antibody positive. Forty-nine (87.5%) of 56 HCV antibody-positive patients had HCV RNA detected by the polymerase chain reaction. The HCV genotyping was possible in 37 of 49 patients (76%). The HCV genotype distribution was genotype 1a, seven (19%); genotype 1b, 10 (27%); genotype 4a, 11 (30%); unmatched sequences, nine (24%). Phylogenetic analysis of unmatched sequences indicated that they represent two distinct and novel subtypes of HCV genotype 4. Hepatitis G virus RNA was detected in 29 (59%) of the HCV RNA-positive patients. No differences were identified between patients infected with HCV alone and those coinfected with HGV. These data demonstrate that HCV infection is common in this population with a genotype distribution predominantly made up of types 1 and 4. Coinfection with HGV had no effect on the outcome of HCV infection.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9790432     DOI: 10.4269/ajtmh.1998.59.571

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  36 in total

1.  Molecular characterization of a full genome Turkish hepatitis C virus 1b isolate (HCV-TR1): a predominant viral form in Turkey.

Authors:  Esra Yildiz; Asli Oztan; Funda Sar; Ergun Pinarbasi; Rengul Cetin-Atalay; Hikmet Akkiz; Mehmet Ozturk
Journal:  Virus Genes       Date:  2002-10       Impact factor: 2.332

2.  Phylogenetic analysis of hepatitis C virus isolates from Tunisian patients.

Authors:  Ahlem Djebbi; Selma Mejri; Valerie Thiers; Henda Triki
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

Review 3.  Current status and emerging challenges in the treatment of hepatitis C virus genotypes 4 to 6.

Authors:  Vasilios Papastergiou; Stylianos Karatapanis
Journal:  World J Clin Cases       Date:  2015-03-16       Impact factor: 1.337

Review 4.  Prevalence of hepatitis C virus infection among hemodialysis patients in the Middle-East: A systematic review and meta-analysis.

Authors:  Soheil Ashkani-Esfahani; Seyed Moayed Alavian; Mohammad Salehi-Marzijarani
Journal:  World J Gastroenterol       Date:  2017-01-07       Impact factor: 5.742

5.  Hepatitis C virus genotype 3a with phylogenetically distinct origin is circulating in Pakistan.

Authors:  Irshad-Ur Rehman; Muhammad Idrees; Muhammad Ali; Liaqat Ali; Sadia Butt; Abrar Hussain; Haji Akbar; Samia Afzal
Journal:  Genet Vaccines Ther       Date:  2011-01-06

Review 6.  Clinical significance of hepatitis C virus genotypes.

Authors:  N N Zein
Journal:  Clin Microbiol Rev       Date:  2000-04       Impact factor: 26.132

7.  Genotypes of hepatitis C virus (HCV) among positive Lebanese patients: comparison of data with that from other Middle Eastern countries.

Authors:  A I Sharara; S Ramia; F Ramlawi; J Eid Fares; S Klayme; R Naman
Journal:  Epidemiol Infect       Date:  2006-07-19       Impact factor: 2.451

8.  Molecular epidemiology of Hepatitis C virus genotypes in Khyber Pakhtoonkhaw of Pakistan.

Authors:  Amjad Ali; Habib Ahmed; Muhammad Idrees
Journal:  Virol J       Date:  2010-08-26       Impact factor: 4.099

9.  Diversity of Hepatitis C virus in Southern India Based on 5'UTR Sequence.

Authors:  R Amjesh; Achuthsankar S Nair; V S Sugunan
Journal:  Indian J Virol       Date:  2012-09-25

10.  Comparison of hepatitis C virus genotyping by 5' noncoding region- and core-based reverse transcriptase PCR assay with sequencing and use of the assay for determining subtype distribution in India.

Authors:  Kavita S Lole; Jyotsna A Jha; Sandhya P Shrotri; Badri N Tandon; V G Mohan Prasad; Vidya A Arankalle
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.